ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Mental Health
New Drug Could Help Stop Depression, Anxiety, Brain Injury, and Cognitive Disorders
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Vince" data-source="post: 226776" data-attributes="member: 843"><p>A new preclinical drug reported by James Bibb, Ph.D., and colleagues has the potential to combat depression, brain injury, and cognitive disorders. The drug, which is notable for being brain-permeable, works by inhibiting the kinase enzyme Cdk5.</p><p></p><p></p><p></p><p>Cdk5 is an important signaling regulator in brain neurons. Over three decades of research, it has been linked to neuropsychiatric and degenerative disorders such as Alzheimer’s</p><p></p><p>Alzheimes disease is a disease that attacks the brain, causing a decline in mental ability that worsens over time. It is the most common form of dementia and accounts for 60 to 80 percent of dementia cases. There is no current cure for Alzheimers disease, but there are medications that can help ease the symptoms. Alzheimer’s and Parkinson’s. Knocking out the enzyme in mice makes them more resilient to stress, improves cognition, protects neurons from stroke and brain trauma, and slows neurodegeneration.</p><p></p><p>[URL unfurl="true"]https://scitechdaily-com.cdn.ampproject.org/v/s/scitechdaily.com/new-drug-could-help-stop-depression-anxiety-brain-injury-and-cognitive-disorders/amp/?amp_gsa=1&amp_js_v=a9&usqp=mq331AQIKAGwASCAAgM%3D#amp_tf=From%20%251%24s&aoh=16561808973609&csi=0&referrer=https%3A%2F%2Fwww.google.com&ampshare=https%3A%2F%2Fscitechdaily.com%2Fnew-drug-could-help-stop-depression-anxiety-brain-injury-and-cognitive-disorders%2F[/URL]</p></blockquote><p></p>
[QUOTE="Vince, post: 226776, member: 843"] A new preclinical drug reported by James Bibb, Ph.D., and colleagues has the potential to combat depression, brain injury, and cognitive disorders. The drug, which is notable for being brain-permeable, works by inhibiting the kinase enzyme Cdk5. Cdk5 is an important signaling regulator in brain neurons. Over three decades of research, it has been linked to neuropsychiatric and degenerative disorders such as Alzheimer’s Alzheimes disease is a disease that attacks the brain, causing a decline in mental ability that worsens over time. It is the most common form of dementia and accounts for 60 to 80 percent of dementia cases. There is no current cure for Alzheimers disease, but there are medications that can help ease the symptoms. Alzheimer’s and Parkinson’s. Knocking out the enzyme in mice makes them more resilient to stress, improves cognition, protects neurons from stroke and brain trauma, and slows neurodegeneration. [URL unfurl="true"]https://scitechdaily-com.cdn.ampproject.org/v/s/scitechdaily.com/new-drug-could-help-stop-depression-anxiety-brain-injury-and-cognitive-disorders/amp/?amp_gsa=1&_js_v=a9&usqp=mq331AQIKAGwASCAAgM%3D#amp_tf=From%20%251%24s&aoh=16561808973609&csi=0&referrer=https%3A%2F%2Fwww.google.com&share=https%3A%2F%2Fscitechdaily.com%2Fnew-drug-could-help-stop-depression-anxiety-brain-injury-and-cognitive-disorders%2F[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Mental Health
New Drug Could Help Stop Depression, Anxiety, Brain Injury, and Cognitive Disorders
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top